Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28254032 | 1.00 | CNR1 (0.51) | CNR1KDM4ENFKB1NFKB2RELA | |
| SCHEMBL27170370 | 0.98 | KDM4E (0.53) | CNR1KDM4ENFKB1NFKB2RELA | |
| SCHEMBL31254100 | 0.98 | KDM4E (0.53) | CNR1KDM4ENFKB1NFKB2RELA | |
| SCHEMBL10526321 | 0.93 | FFAR1 (0.55) | SOAT1FFAR1FFAR4MEN1ALDH1A1 | |
| SCHEMBL29131470 | 0.93 | FFAR1 (0.55) | SOAT1FFAR1FFAR4MEN1ALDH1A1 | |
| SCHEMBL27987561 | 0.93 | FFAR1 (0.55) | SOAT1FFAR1FFAR4MEN1ALDH1A1 | |
| SCHEMBL4602415 | 0.93 | FFAR1 (0.55) | SOAT1FFAR1FFAR4MEN1ALDH1A1 | |
| SCHEMBL4616055 | 0.93 | FFAR1 (0.55) | SOAT1FFAR1FFAR4MEN1ALDH1A1 | |
| SCHEMBL13371693 | 0.89 | NFKB1 (0.55) | CNR1KDM4ENFKB1NFKB2RELA | |
| SCHEMBL17743969 | 0.89 | NFKB1 (0.55) | CNR1KDM4ENFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116835903-B | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-118284419-A | Methods of treating post-traumatic stress disorder | 杰资制药爱尔兰有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117957234-A | Thienopyrrole compounds | 吉利德科学公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117120450-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117069411-A | Multi-ring structure shrinkage reducing agent, alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116835903-A | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116783202-A | Thienopyrrole compounds | 吉利德科学公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116835903-B | Shrinkage-reducing alkali-free liquid accelerator and preparation method thereof | 陕西科之杰新材料有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4577247-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | The Johns Hopkins University (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4003384-B1 | AN EXTRACT FROM CANNABIS AND PEGANUM | T C ERCIYES UNIV (TR) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025108106-A1 | COMPOUND CONTAINING QUINOLINONE SKELETON AND USE THEREOF | 中国药科大学 | 2025-05-30 | — | — | WO | disclosed |
| CN-119881144-A | Method for extracting and detecting lipid in liquid milk raw milk | 上海市质量监督检验技术研究院 | 2025-04-25 | — | — | CN | disclosed |
| WO-2007030697-A2 | MODULATION OF NEUROGENESIS BY HDAC INHIBITION | BRAINCELLS, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007025177-A2 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2007-03-01 | — | — | WO | disclosed |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2007-03-01 | — | — | US | disclosed |
| WO-2006133926-A1 | PYRAZOLE DERIVATES AS CANNABINOID RECEPTOR MODULATORS | CAREX SA (FR) | 2006-12-21 | — | — | WO | disclosed |
| WO-2005113600-A2 | METHODS FOR THE CONTROL, TREATMENT AND MANAGEMENT OF OBESITY | HAPTOGEN LTD (GB) | 2005-12-01 | — | — | WO | disclosed |
| US-20040132819-A1 | Appetite control method | ABBOTT LABORATORIES | 2004-07-08 | — | — | US | disclosed |
| WO-2004012727-A1 | COMPOSITIONS COMPRISING POLYSATURATED FATTY ACID (PUFAS) FOR THE CONTROL OF APPETITE AND BODY WEIGHT MANAGEMENT | ABBOTT LABORATORIES (US) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | CNR1, CNR2, GPR18 | CNR1 1/4885KDM4E 1372/4885NFKB1 4295/4885 |
| US-20070049576-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | CNR1 198/4885KDM4E 2095/4885NFKB1 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.